For Rave-Ready Electronic Duo the Chemical Brothers, a 10th Studio Album Is a Feat and a Challenge

Ed Simons, left, and Tom Rowlands of the Chemical Brothers perform onstage at Field Day, Aug. 20, 2022, at Victoria Park in London. (AP)
Ed Simons, left, and Tom Rowlands of the Chemical Brothers perform onstage at Field Day, Aug. 20, 2022, at Victoria Park in London. (AP)
TT

For Rave-Ready Electronic Duo the Chemical Brothers, a 10th Studio Album Is a Feat and a Challenge

Ed Simons, left, and Tom Rowlands of the Chemical Brothers perform onstage at Field Day, Aug. 20, 2022, at Victoria Park in London. (AP)
Ed Simons, left, and Tom Rowlands of the Chemical Brothers perform onstage at Field Day, Aug. 20, 2022, at Victoria Park in London. (AP)

Beloved British electronic duo the Chemical Brothers released their 10th album on Friday, more than three decades into their career. But does it get any easier with time?

Not according to one-half of the outfit, Tom Rowlands.

“I think it’s just more complicated” he said, speaking via Zoom from his studio in the UK. “Everyone’s got a new theory on how to do it.”

Prior to the album’s release, Rowlands and Ed Simons shared four singles from the forthcoming album, “For That Beautiful Feeling” — including their second collaboration with Beck, the track “Skipping Like A Stone.” They previously worked with the singer on the 2015 track “Wide Open.”

They also made it a point to test the tracks out on dance floors and festival fields prior to the album — “playing them (live) as we write them,” as Rowlands explains — which, in turn, influenced their studio decisions.

“I don’t know if it’s the right way to release an album,” he smiled. “I can’t quite keep up with what is the right way, but it’s how it’s happening.”

It’s working. Audiences responded well to the smattering of tracks from “For That Beautiful Feeling” that the Chemical Brothers wove into their sets this summer, no doubt drumming up excitement for the new release.

The rave-ready “No Reason” became the lead single from the record — because it felt “fresh and different” and also “really fun to play live,” says Rowlands. But really, it’s all about how he and Simons feel about the track — and sometimes if a song doesn’t go over well in front of an audience, well, that just solidifies its value to the duo.

“Sometimes something going down really badly, will just convince you of its greatness even more,” Rowlands says of this live-first tactic. “You’re like, ‘Yes. People aren’t ready for this!’”

Together since 1989, with 10 albums and countless performances across the globe, the duo has seen their fair share of the good and the bad.

Headlining the Pyramid Stage at Glastonbury Festival in 2000 is a standout — though Rowlands says it was “so massive it’s hard to get a handle on what you’re doing.”

And then there’s the bad: A very different experience during a 9:30 a.m. set in Ibiza, early on in their career that didn’t quite go to plan.

They were “the wrong people at the wrong place at the wrong time,” Rowlands recalled. “Just lots of anger and tears ... sensible people would’ve gone to bed and then have a nice juice breakfast.”

For the nighttime live music lovers, the Chemical Brothers are looking forward to getting back on the road for a tour that kicks off Oct. 26 in Glasgow. They’re eager to use stunning visuals from longtime collaborators Adam Smith and Marcus Lyall — and test drive additional music that didn’t make the record, or as Rowlands puts it: “thousands of hours of noodling.”

On tour, “you can do your lights exactly how you want and get everything really tuned to how you want it to be,” Rowlands added. “That’s really exciting for us.”

In addition to the new album and the tour, the duo will release a book in October titled “Paused in Cosmic Reflection,” authored by Simons and Rowlands’ friend Robin Turner, with their input. But as a band who are constantly looking forward, it isn’t something Rowlands is quite ready to read.

“I’m going to save it for a flight or retirement.” He smiled.



Doctor Charged in Connection with Matthew Perry’s Death to Appear in Court After Plea Deal 

Actor Matthew Perry poses at the CBS Studios rooftop summer soiree in West Hollywood, California May 18, 2015. (Reuters)
Actor Matthew Perry poses at the CBS Studios rooftop summer soiree in West Hollywood, California May 18, 2015. (Reuters)
TT

Doctor Charged in Connection with Matthew Perry’s Death to Appear in Court After Plea Deal 

Actor Matthew Perry poses at the CBS Studios rooftop summer soiree in West Hollywood, California May 18, 2015. (Reuters)
Actor Matthew Perry poses at the CBS Studios rooftop summer soiree in West Hollywood, California May 18, 2015. (Reuters)

One of two doctors charged in connection with Matthew Perry's death is set to appear Friday in a federal court in Los Angeles, where he is expected to plead guilty to conspiring to distribute the surgical anesthetic ketamine.

Dr. Mark Chavez, 54, of San Diego, reached a plea agreement with prosecutors earlier this month and would be the third person to plead guilty in the aftermath of the “Friends” star’s fatal overdose last year.

Chavez agreed to cooperate with prosecutors as they pursue others, including the doctor Chavez worked with to sell ketamine to Perry. Also working with the US Attorney's Office are Perry’s assistant, who admitted to helping him obtain and inject ketamine, and a Perry acquaintance, who admitted to acting as a drug messenger and middleman.

The three are helping prosecutors as they go after their main targets: Dr. Salvador Plasencia, charged with illegally selling ketamine to Perry in the month before his death, and Jasveen Sangha, a woman who authorities say is a dealer who sold the actor the lethal dose of ketamine. Both have pleaded not guilty and are awaiting trial.

Chavez admitted in his plea agreement that he obtained ketamine from his former clinic and from a wholesale distributor where he submitted a fraudulent prescription.

After a guilty plea, he could get up to 10 years in prison when he is sentenced.

Perry was found dead by his assistant on Oct. 28. The medical examiner ruled ketamine was the primary cause of death. The actor had been using the drug through his regular doctor in a legal but off-label treatment for depression that has become increasingly common.

Seeking more ketamine than his doctor would give him, about a month before his death Perry found Plasencia, who in turn asked Chavez to obtain the drug for him.

“I wonder how much this moron will pay,” Plasencia texted Chavez. The two met up the same day in Costa Mesa, halfway between Los Angeles and San Diego, and exchanged at least four vials of ketamine.

After selling the drugs to Perry for $4,500, Plasencia asked Chavez if he could keep supplying them so they could become Perry’s “go-to.”

US Attorney Martin Estrada said in announcing the charges on Aug. 15 that “the doctors preyed on Perry’s history of addiction in the final months of his life last year to provide him with ketamine in amounts they knew were dangerous.”

Plasencia is charged with seven counts of distribution of ketamine and two charges related to allegations he falsified records after Perry’s death. He and Sangha are scheduled to return to court next week. They have separate trial dates set for October, but prosecutors are seeking a single trial that likely would be delayed to next year.

Perry struggled with addiction for years, dating back to his time on “Friends,” when he became one of the biggest stars of his generation as Chandler Bing. He starred alongside Jennifer Aniston, Courteney Cox, Lisa Kudrow, Matt LeBlanc and David Schwimmer for 10 seasons from 1994 to 2004 on NBC’s megahit sitcom.